How are the sclerotic skin lesions of hypothyroidism typically distributed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sclerotic Skin Lesions in Hypothyroidism: Distribution Patterns

Direct Answer

The question appears to conflate two distinct conditions: hypothyroidism does not typically cause sclerotic skin lesions. The provided evidence addresses scleroderma (systemic sclerosis and localized scleroderma), which is an autoimmune connective tissue disease unrelated to hypothyroidism, and sclerotic bone lesions that may occur with hypothyroidism in specific contexts.

Clarification of Terminology

Hypothyroidism and Skin Manifestations

  • Hypothyroidism causes dry skin (xeroderma), not sclerotic lesions 1, 2
  • Common dermatologic findings in hypothyroidism include dry skin, coarse skin, and myxedema, but not scleroderma-type sclerotic changes 2, 3

Sclerotic Bone Lesions Associated with Hypothyroidism

If the question refers to sclerotic bone lesions occurring in patients with hypothyroidism:

  • Bilateral symmetric osteosclerosis of the meta-diaphysis of the femur, tibia, and fibula occurs in 95% of Erdheim-Chester Disease (ECD) cases, which can cause hypothyroidism in 20% of patients 4
  • The American Society of Hematology recommends considering ECD in patients presenting with both sclerotic bone lesions and hypothyroidism 4
  • The characteristic distribution is lower extremity long bones with bilateral symmetric involvement 4

Localized Scleroderma (If Confusion Exists)

If referring to localized scleroderma (which is NOT caused by hypothyroidism):

Linear Scleroderma Distribution

  • Linear scleroderma is the most common subtype in children and follows specific patterns 5
  • When involving the face and head, distribution follows developmental facial units: frontotemporal, maxillary, mandibular, and frontonasal patterns 6

Systemic Sclerosis Distribution

  • Limited cutaneous systemic sclerosis (lcSSc) involves skin distal to elbows and/or knees without truncal involvement, though face and neck may be affected 5
  • Diffuse cutaneous systemic sclerosis (dcSSc) involves skin both distal and proximal to knees and/or elbows and/or truncal areas 5

Clinical Pitfall

The critical pitfall is confusing hypothyroidism with scleroderma. These are separate disease entities:

  • Hypothyroidism is an endocrine disorder causing thyroid hormone deficiency 1, 2
  • Scleroderma is an autoimmune connective tissue disease with fibrosis and vasculopathy 5
  • They may rarely coexist but are not causally related 4

Assessment Recommendations (If Scleroderma is Present)

  • All patients with localized scleroderma involving face and head should have MRI of the head at diagnosis 5, 6
  • Ophthalmological assessment including uveitis screening is recommended at diagnosis for facial/scalp lesions 5
  • The Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) is highly recommended for assessing activity and severity 5, 6

References

Research

Hypothyroidism.

Lancet (London, England), 2017

Research

Unusual presentations of hypothyroidism.

The American journal of the medical sciences, 1997

Guideline

Sclerotic Bone Lesions in Hypothyroidism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Manifestations and Diagnostic Considerations in Parry-Romberg Syndrome and Localized Craniofacial Scleroderma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.